Department of Hand and Foot Surgery, The First Hospital of Jilin University, Changchun, Jilin, China.
Front Immunol. 2023 Feb 6;14:911368. doi: 10.3389/fimmu.2023.911368. eCollection 2023.
Osteosarcoma is the most frequent primary bone tumor with a poor prognosis. Immune infiltration proved to have a strong impact on prognosis. We analyzed single-cell datasets and bulk datasets to confirm the main immune cell populations and their properties in osteosarcoma.
The examples in bulk datasets GSE21257 and GSE32981 from the Gene Expression Omnibus database were divided into two immune infiltration level groups, and 34 differentially expressed genes were spotted. Then, we located these genes among nine major cell clusters and their subclusters identified from 99,668 individual cells in single-cell dataset GSE152048 including 11 osteosarcoma patients. Especially, the markers of all kinds of myeloid cells identified in single-cell dataset GSE152048 were set to gene ontology enrichment. We clustered the osteosarcoma samples in the TARGET-OS from the Therapeutically Applicable Research to Generate Effective Treatments dataset into two groups by complete component 1q positive macrophage markers and compared their survival.
Compared with the low-immune infiltrated group, the high-immune infiltrated group showed a better prognosis. Almost all the 34 differentially expressed genes expressed higher or exclusively among myeloid cells. A group of complete component 1q-positive macrophages was identified from the myeloid cells. In the bulk dataset TARGET-OS, these markers and the infiltration of complete component 1q-positive macrophages related to longer survival.
Complete component 1q-positive tumor-associated macrophages were the major immune cell population in osteosarcoma, which contributed to a better prognosis.
骨肉瘤是最常见的原发性骨肿瘤,预后不良。免疫浸润已被证明对预后有很大影响。我们分析了单细胞数据集和批量数据集,以确认骨肉瘤中的主要免疫细胞群及其特性。
从基因表达综合数据库中获取批量数据集 GSE21257 和 GSE32981 的示例,将其分为两个免疫浸润水平组,并确定了 34 个差异表达基因。然后,我们在单细胞数据集 GSE152048 中确定的 99668 个个体细胞的 9 个主要细胞簇及其亚簇中定位了这些基因,该数据集包括 11 例骨肉瘤患者。特别是,在单细胞数据集 GSE152048 中鉴定的各种髓样细胞的标记物被设置为基因本体富集。我们根据完整组分 1q 阳性巨噬细胞标记物,将治疗适用研究靶向骨肉瘤(TARGET-OS)数据集的骨肉瘤样本聚类为两组,并比较其生存情况。
与低免疫浸润组相比,高免疫浸润组的预后更好。34 个差异表达基因几乎全部在髓样细胞中表达更高或特异性表达。从髓样细胞中鉴定出一组完整组分 1q 阳性巨噬细胞。在批量数据集 TARGET-OS 中,这些标记物和完整组分 1q 阳性巨噬细胞的浸润与更长的生存时间相关。
完整组分 1q 阳性肿瘤相关巨噬细胞是骨肉瘤中的主要免疫细胞群,有助于改善预后。